CYTOKINETICS INC - COMMON STOCK (CYTK)

CUSIP: 23282W605

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
122,181,876
Total 13F shares
108,867,212
Share change
+2,817,563
Total reported value
$3,829,923,005
Put/Call ratio
100%
Price per share
$35.19
Number of holders
259
Value change
+$81,444,143
Number of buys
116
Number of sells
137

Quarterly Holders Quick Answers

What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2023

As of 31 Mar 2023, CYTOKINETICS INC - COMMON STOCK (CYTK) was held by 259 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 108,867,212 shares. The largest 10 holders included BlackRock Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, AMERICAN CENTURY COMPANIES INC, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PFM Health Sciences, LP, and LORD, ABBETT & CO. LLC. This page lists 260 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.